Recently many antiangiogenic and steroid drugs have been proposed in the treatment of exudative AMD and other rare retinal diseases and among these, ranibizumab in particular, administered by intravitreal injections, was mainly used in the treatment of exudative AMD [ 4– 10].
These potential changes should be considered in particular when administering ferumoxytol to patients with expected future PET/MR studies, as ferumoxytol-induced SUV changes might interfere with therapy assessment.
In particular, researchers administering the Hospital Survey on Patient Safety Culture (HSPSC), developed by the U.S. Agency for Healthcare Research and Quality (AHRQ), outside the U.S. often identify different underlying constructs and generally document lower internal consistency reliability [ 18- 20].
Furthermore, the 'primum non nocere-principle' (= 'first, do not harm') was mentioned as a basic principle of quality, in particular, when administering substances to a patient such as phytotherapy or Chinese drugs.
In conclusion, the risk of AKI from CM, in particular when administered intravenously for contrast-enhanced CT, has been exaggerated by older, noncontrolled studies.
In particular, treatments administered early during the stimulation phase of the cycle, and treatment on the day of ET (Table 2).
In particular, when administered in vivo, they could participate in the formation and modulation of the recently named "atypical ectopic perivascular niches" in the context of inflammatory disorders of the CNS [ 52].
When high-dose AT, in particular, was administered with either unfractionated or low-molecular-weight heparin, the number of bleeding events increased significantly (23.8% for AT with heparin versus 13.5 for placebo; P <0.001) in KyberSept [ 5].
In particular, when administered orally at the beginning of rat senescence, BCAAem induces eNOS and vascular endothelial growth factor in the kidney, thus increasing vascularization and reducing kidney fibrosis.
Na+-channel and β-blockers (such as phenytoin and propanolol, respectively) are being tested for LQT treatment in animal models, but further studies are needed to fully characterise their action, in particular when administered chronically.
